Vijay Vaithi Swaran

Vijay Vaithi Swaran, U.S. business editor for The Economist, unpacks the shifting perception of big pharma during the pandemic. He discusses how vaccine development has elevated drug firms from scrutiny to vital innovators. The conversation also delves into the future of remote work, exploring its significant impact on commercial real estate and urban demographics. Additionally, Swaran touches on the political situation in Hong Kong, linking tumultuous changes in education to broader civic freedoms.

Vijay Vaithi Swaran, U.S. business editor for The Economist, sheds light on the dramatic shift in perceptions towards the pharmaceutical industry during the COVID-19 pandemic. He discusses how vaccine innovation has altered reputations and emphasizes the importance of equitable access, especially in developing nations. The conversation also touches on the ramifications of remote work on productivity and urban structures, alongside the escalating political tensions in Hong Kong, highlighted by a controversial history exam that reflects deeper societal issues.